newsfilter
← Latest News
GlobeNewswire·

Oragenics, Inc. Provides Q1 2025 Shareholder Update on Strategic and Financial Progress

SARASOTA, Fla., March 27, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE:OGEN), a biotechnology company focused on developing novel intranasal therapies for brain-related conditions, today provided shareholders with an